Systems and methods for promoting reactions between multiple chambers of an inspection apparatus

JP2023549487A5Inactive Publication Date: 2024-11-19PRESIDENT & FELLOWS OF HARVARD COLLEGE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023527737
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-10-21
Filing Date
2021-11-12
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Centralized testing infrastructure for pandemics strains resources and delays test results, necessitating decentralized testing solutions that require user-friendly, error-proof equipment for the general public.

Method used

A testing device with multiple chambers and a spring mechanism that allows for controlled fluid movement between compartments using a spring retainer to ensure accurate chemical reactions, including a solenoid for automated advancement.

Benefits of technology

Enables efficient, cost-effective, and user-friendly decentralized testing by ensuring accurate chemical reactions and reducing the risk of errors in sample processing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The inspection device includes an elongated member and a tube assembly. The tube assembly has a first end and a second end. The tube assembly is configured to receive the elongated member at the second end. The tube assembly includes a plurality of chambers, including a first chamber and a second chamber. The first chamber and the second chamber are separated by a membrane. The tube assembly further includes a spring disposed at the second end of the tube assembly. The tube assembly includes a spring retainer configured to prevent the spring from decompressing when in a locked position and to allow the spring to decompress when in an unlocked position.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0004] , , ,

[0001] Cross - Reference to Related Applications This application claims priority and benefit to U.S. Provisional Patent Application No. 63 / 112,751, filed on November 12, 2020; U.S. Provisional Patent Application No. 63 / 124,919, filed on December 14, 2020; U.S. Provisional Patent Application No. 63 / 126,701, filed on December 17, 2020; U.S. Provisional Patent Application No. 63 / 191,205, filed on May 20, 2021; and U.S. Provisional Patent Application No. 63 / 270,350, filed on October 21, 2021, each of which is hereby incorporated by reference in its entirety.

[0002] Description of Research Funded by the Federal Government This invention was made with government support under Grant No. GM133052 awarded by the National Institutes of Health. The government has certain rights in this invention.

[0003] <00​​​​​​​Pandemics or epidemics requiring large-scale testing (e.g., the COVID-19 pandemic) strain testing resources based on centralized testing infrastructure, for example, when a small number of testing laboratories or centers are involved in providing test results to the public. Democratizing or decentralizing testing can significantly improve efficiency by removing obstacles associated with centralized infrastructure. For example, test results can be provided to people more quickly in a more decentralized testing environment. However, such decentralized testing requires materials and equipment that can be used by the general public who may not be familiar with the testing process. Therefore, this disclosure relates to error-preventing testing equipment for various applications. [Prior art documents] [Patent Documents]

[0005] [Patent Document 1] U.S. Patent Application Publication No. 2014 / 0004548 [Patent Document 2] International Publication No. 2019 / 204147 [Patent Document 3] U.S. Patent Application Publication No. 2014 / 0120544 [Overview of the project] [Means for solving the problem]

[0006] According to some implementations of this disclosure, an inspection apparatus is provided. The apparatus includes an elongated member and a tube assembly. The tube assembly has a first end and a second end. The tube assembly is configured to receive the elongated member at the second end. The tube assembly includes a plurality of chambers, including a first chamber and a second chamber. The first chamber and the second chamber are separated by a membrane. The tube assembly further includes a spring located at the second end of the tube assembly. The tube assembly further includes a spring retainer configured to prevent the spring from depressurizing when in the locked position and to allow the spring to depressurize when in the unlocked position.

[0007] According to some implementations of the present disclosure, a method for carrying out a chemical reaction is provided. This method includes (a) inserting one end of an elongated member into a second end of a tube assembly so that one end of the elongated member extends into a first chamber of the tube assembly; (b) depressurizing a spring located at the second end of the tube assembly by unlocking a spring retainer of the tube assembly; and (c) perforating a membrane separating the first chamber of the tube assembly from the second chamber of the tube assembly so that one end of the elongated member extends into the second chamber of the tube assembly.

[0008] According to some implementations of the present disclosure, a method for carrying out a chemical reaction is provided. This method includes (a) inserting a cotton swab into a first chamber of an inspection device, the first chamber containing a first fluid mixture; (b) depressurizing a first spring located in a first spring chamber of the inspection device, the depressurization of the first spring causing the fluid mixture in the first chamber to flow into the first spring chamber of the inspection device, and the fluid mixture being filtered by silica on its way to the first spring chamber; and (c) depressurizing a second spring located in a second spring chamber of the inspection device, the depressurization of the second spring causing a second fluid in the second spring chamber of the inspection device to be filtered by silica on its way to the second chamber.

[0009] The above summary is not intended to represent any or all aspects of this disclosure. Additional features and benefits of this disclosure are evident from the detailed description and figures provided below.

[0010] This patent or application document includes at least one drawing drawn in color. A copy of this patent or patent application publication containing the color drawing(s) will be provided by the Patent and Trademark Office upon request and payment of the required fees. [Brief explanation of the drawing]

[0011] [Figure 1] This disclosure provides an example of an inspection apparatus based on several implementations of this disclosure. [Figure 2] Figure 1 shows an exploded view of the inspection apparatus, based on several implementations of the present disclosure. [Figure 3] Figure 1 shows a cross-sectional view of an exploded inspection apparatus, based on several implementations of the present disclosure. [Figure 4] A cross-section of a first configuration of the inspection apparatus shown in Figure 1, according to several implementations of the present disclosure, is shown. [Figure 5] A cross-section of a second configuration of the inspection apparatus shown in Figure 1, based on several implementations of the present disclosure, is shown. [Figure 6-1] A cross-section of a second exemplary inspection apparatus, based on several implementations of the present disclosure, is shown. [Figure 6-2] A cross-section of a third exemplary inspection apparatus, based on several implementations of this disclosure, is shown. [Figure 6-3] A cross-section of a fourth exemplary inspection apparatus, based on several implementations of this disclosure, is shown. [Figure 6-4] A cross-section of a fifth exemplary inspection apparatus, based on several implementations of this disclosure, is shown. [Figure 7] This disclosure outlines the processes for performing inspections using several implementations of this disclosure. [Figure 8A] A cross-section of a first exemplary electronic device, based on several implementations of this disclosure, is shown. [Figure 8B] A cross-section of a second exemplary electronic device, based on several implementations of this disclosure, is shown. [Figure 9] An exemplary modular assembly of an electronic device according to some implementations of the present disclosure is shown. [Figure 10] A sixth exemplary inspection device according to some implementations of the present disclosure is shown. [Figure 11] A cross-section of the sixth inspection device of FIG. 10 according to some implementations of the present disclosure is shown. [Figure 12A] A cross-section of a seventh exemplary inspection device according to some implementations of the present disclosure is shown. [Figure 12B] A cross-section of the seventh inspection device at a first position according to some implementations of the present disclosure is shown. [Figure 12C] A cross-section of the seventh inspection device at a second position according to some implementations of the present disclosure is shown. [Figure 12D] A cross-section of the seventh inspection device at a third position according to some implementations of the present disclosure is shown. [Figure 12E] A cross-section of the seventh exemplary inspection device at a fourth position according to some implementations of the present disclosure is shown. [Figure 13] A cross-section of an eighth exemplary inspection device according to some implementations of the present disclosure is shown. [Figure 13-1] A cross-section of a portion of a ninth exemplary inspection device according to some implementations of the present disclosure is shown. [Figure 14] A cross-section of a tenth exemplary inspection device according to some implementations of the present disclosure is shown. [Figure 15] Steps for using an exemplary inspection device according to some implementations of the present disclosure are shown.

[0012] Although the present disclosure is capable of various modifications and alternative forms, specific implementations and embodiments thereof are shown by way of example in the drawings and are described in detail herein. However, it should be understood that the present disclosure is not intended to be limited to the particular forms disclosed, but rather includes all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure as defined by the appended claims.

MODE FOR CARRYING OUT THE INVENTION

[0013] Embodiments of the present disclosure provide a simple and inexpensive system and method for carrying out biochemical reactions requiring multiple consecutive compartments or chambers, whether due to different reagents, temperatures, or other requirements. In some implementations, a mechanism for storing potential energy is described, which can be released by a simple mechanical initiator to result in fluid movement between chambers. For example, the potential energy may be stored as a user-compressed or pre-compressed spring, and a solenoid initiates the release of the spring energy, forcing fluid movement from a first chamber to a second chamber by a syringe mechanism.

[0014] Various embodiments are described with reference to the accompanying drawings, where similar reference numbers are used throughout the drawings to indicate similar or equivalent elements. The drawings are not necessarily drawn to a specific scale and are provided solely to illustrate the aspects and features of the disclosure. Numerous specific details, relationships, and methods are described to provide a complete understanding of the particular aspects and features of the disclosure, but those skilled in the art will recognize that these aspects and features may be put into practice by other relationships or other methods without the need for one or more specific details. In some examples, well-known structures or operations are not shown in detail for illustrative purposes. The various embodiments disclosed herein are not necessarily limited by the order of the illustrated actions or events, and some actions may occur in a different order and / or concurrently with other actions or events. Furthermore, not all illustrated actions or events are necessarily required to implement the particular aspects and features of the disclosure.

[0015] For the purpose of describing the present invention in detail, unless otherwise specified, singular forms include plural forms where appropriate. The word “including” means “including without limitation.” Furthermore, approximate words, such as “about,” “almost,” “substantially,” “generally,” etc., may be used herein to mean “at,” “near,” “approximately,” “within 3-5%,” “within acceptable manufacturing tolerances,” or any logical combination thereof. Similarly, the terms “vertical” or “horizontal” are intended to further include “within 3-5%” in the vertical or horizontal direction, respectively. In addition, directional words, such as “top,” “bottom,” “left,” “right,” “up,” “down,” etc., are intended to relate to equivalent directions from the referenced object(s) or element(s) as shown in the reference drawings, as understood in context from a position commonly used for the object(s) or element(s), or as otherwise stated herein.

[0016] Figure 1 shows an inspection device 100 according to several implementations of the present disclosure. The inspection device 100 may allow a reaction to proceed from one chamber of the inspection device to another chamber of the inspection device. The inspection device 100 can be an inexpensive, disposable device. The inspection device 100 may include an elongated member 102 and a tube assembly 104 having a first end 112 and a second end 110. The elongated member 102 may be a cotton swab, a syringe, etc. The elongated member 102 is configured to be inserted into the tube assembly 104 at the second end 110. In Figure 1, the tube assembly 104 is shown as a pre-assembled part of the inspection device 100.

[0017] Figure 2 shows an exploded view of the components of the inspection device 100 according to several implementations of the present disclosure. In particular, Figure 2 shows different parts of the pre-assembled tube assembly 104 of Figure 1. The tube assembly 104 includes a first cylindrical member 202, a spring 204, a spring retainer 206, a first chamber casing 208 defining the first chamber 407 (Figure 4), and a second chamber casing 210 defining the second chamber 409 (Figure 4). Figure 3 shows a cross-sectional exploded view of the inspection device 100 according to several implementations of the present disclosure. Each of the elongated member 102, the first cylindrical member 202, the spring retainer 206, the first chamber casing 208, and the second chamber casing 210 may be made of plastic or other material. Examples of materials include acrylonitrile butadiene styrene (ABS), polypropylene, polycarbonate, nylon, and 3D printed materials. In some implementations, components under stress or subjected to mechanical creep (e.g., spring retainer 206) may be metal. Examples of metals include steel and aluminum. Spring 204 is typically a steel spring in some implementations.

[0018] The first cylindrical member 202 is hollow and may include a key opening 212 along its side wall. The key opening 212 may be a hole in the first cylindrical member 202. The axis of the key opening 212 may be perpendicular to the longitudinal axis of the first cylindrical member 202. While a single key opening 212 is shown for the tube assembly 104, in some implementations, multiple key openings may be provided in sequence, for example, along the side wall of the first cylindrical member 202. The key opening 212 provides a catch and can receive a projection 316 or other part of a spring retainer 206 when the tube assembly 104 is pre-assembled as shown in Figure 1. The spring retainer 206 is hollow and substantially cylindrical and may have an inner radius smaller than the inner radius of the first cylindrical member 202 of the tube assembly 104. The spring retainer 206 may fit within the hollow structure of the first cylindrical member 202.

[0019] If the projection 316 of the spring retainer 206 does not penetrate the key opening 212 of the first cylindrical member 202, the spring retainer 206 is unlocked and moves freely within the hollow first cylindrical member 202. The spring 204 can press against the spring retainer 206, causing it to move along the longitudinal axis of the first cylindrical member 202. If the projection 316 of the spring retainer 206 penetrates the key opening 212 of the first cylindrical member 202, the spring retainer 206 is locked and therefore maintains its position relative to the first cylindrical member 202.

[0020] The spring 204 prevents the spring retainer 206 from moving when the spring retainer 206 is in the locked position. In some implementations, the spring 204 is compressed and stores potential energy when the spring retainer 206 is in the locked position. That is, when the spring retainer 206 is in the locked position, it prevents the spring 204 from depressurizing, and when it is in the unlocked position, the spring 204 depressurizes, allowing the spring retainer 206 to move longitudinally along the first cylindrical member 202.

[0021] A spring retainer 206 that is locked and does not move along the pipe assembly 104, or a spring retainer 206 that is unlocked and can move along the pipe assembly 104, can affect the position of the elongated member 102. The elongated member 102 is inserted into the second end 110 of the pipe assembly 104. The elongated member 102 may have a tip 308 and a handle end 302. The tip 308 of the elongated member 102 is inserted into the second end 110 of the pipe assembly 104. The handle end 302 facilitates the user to manually handle the elongated member 102 and position it within the pipe assembly 104.

[0022] The elongated member 102 may be configured to include multiple sections between the tip 308 and the handle end 302. In some implementations, the elongated member 102 includes a cylindrical section 314 having a constant radius, a flared section 304 having a varying radius, the radius of which increases over the length of the flared section 304 as it extends away from the cylindrical section 314, and a stopper section 312 having one or more flaps 306 to prevent the elongated member 102 from coming out of the pipe assembly 104 once inserted.

[0023] In some implementations, the elongated member 102 further includes a protrusion 310. The protrusion 310 can be used to secure an O-ring to the elongated member 102, so that when the tip 308 of the elongated member 102 is inserted into the second end 110 of the tube assembly 104, the O-ring can form an interference fit between the first chamber casing 208 and the elongated member 102. In some implementations, the O-ring may be replaced with a component having a simpler manufacturing process (e.g., a "two-shot" process using thermoplastic elastomer (TPE) or similar) as an integrated seal. In some implementations, the elongated member 102 is configured to be tightly fitted to the first chamber casing 208, so that there is little to no liquid loss when the liquid is injected into the first chamber.

[0024] Figure 4 shows a cross-section of a first configuration of the inspection apparatus 100 according to several implementations of the present disclosure. The tube assembly 104 is pre-assembled in Figure 4. In the construction of the tube assembly 104, the first cylindrical member 202 is attached to the first chamber casing 208, which is attached to the second chamber casing 210. The spring retainer 206 is in a locked position, and as a result, the projection 316 of the spring retainer 206 penetrates the key opening 212 of the first cylindrical member 202. The spring 204 is compressed and positioned at the second end 110 of the tube assembly 104. The compressed spring 204 presses against the spring retainer 206, but the projection 316 prevents the spring retainer 206 from separating from the second end 110 of the tube assembly 104.

[0025] In the first configuration, the elongated member 102 is inserted into the tube assembly 104 so that the tip 308 of the elongated member 102 is positioned within the first chamber 407 defined by the first chamber casing 208. A seal 402 or membrane is provided to separate the volume of the first chamber 407 defined by the first chamber casing 208 from the volume of the second chamber 409 defined by the second chamber casing 210. In the first configuration, the seal 402 is not breached by the tip 308 of the elongated member 102. In some implementations, the seal may be provided in the first chamber casing 208 such that the tip 308 of the elongated member 102 penetrates the seal and enters the first chamber 407.

[0026] In the first configuration, the elongated member 102 is prevented from being further pushed into the tube assembly 104 by the spring retainer 206. The radius of the elongated member 102 in portion 406a is equal to or greater than the inner radius of the spring retainer 206, and as a result, pushing the elongated member 102 into the tube assembly 104 causes interference between the elongated member 102 and the spring retainer 206 in portion 406a, and as a result the elongated member 102 cannot pass any further into the spring retainer 206. Although interference is provided here as an example, the elongated member 102 may be coupled to the spring retainer 206 using other mechanical alternatives. In some implementations, instead of portion 406a of the elongated member 102, portion 406b of the elongated member 102 may be provided with a radius equal to or greater than the inner radius of the spring retainer 206, resulting in interference that prevents the elongated member 102 from being further pressed against the spring retainer 206 by pressing it into the tube assembly 104. In some implementations, both portions 406a and 406b are provided on the elongated member 102. Other alternative means of causing interference that prevents the elongated member 102 from being further pressed against the spring retainer 206 may also be used. For example, instead of causing interference by varying the radius along the elongated member 102, the inner radius of the spring retainer 206 may be reduced at one end, and portion 406a of the elongated member 102 may be larger at one end than the reduced inner radius.

[0027] Interference between the elongated member 102 and the spring retainer 206 prevents the tip 308 of the elongated member 102 from moving further toward the first end 112 of the tube assembly 104, while the flap 306 prevents the elongated member 102 from being removed from the tube assembly 104. The flap 306 is configured to catch on the spring retainer 206 when attempting to remove the elongated member 102 from the tube assembly 104. This not only prevents the elongated member 102 from being removed but also helps to drive the elongated member 102 forward together with the spring retainer 206. Specific implementations of the flap(s) 306 can be made in several ways, including the 3D printed configuration shown, and a two-component injection-molded assembly separated at or near the flap (for manufacturing purposes, or to move the flap mechanism into the spring retainer 206 to induce the same unidirectional catch). The first chamber casing 208 includes a flared portion 404 which allows the flap 306 to move the cylindrical member 202 further downward when the spring retainer 206 is released and placed in the unlocked position.

[0028] Figure 5 shows a cross-section of a second configuration of the inspection device 100 according to several implementations of the present disclosure. In the second configuration, the spring retainer 206 is in the unlocked position, and as a result, the projection 316 no longer penetrates the key opening 212. Thus, the spring 204 can press the spring retainer 206 along the longitudinal axis of the pipe assembly 104 toward the first end 112 of the pipe assembly 104. Since the spring retainer 206 is coupled to the elongated member 102 at portion 406a (Figure 4), the elongated member 102 is displaced along the longitudinal axis of the pipe assembly 104 by a similar distance to the spring retainer 206. In some implementations, due to manufacturing tolerances, the elongated member 102 may detach from portion 406a, but the flap 306 engages with the spring retainer 206, displacing the elongated member 102 along the longitudinal axis of the tube assembly 104 to a distance similar to that of the spring retainer 206. In some implementations, portion 406b (Figure 4) of the elongated member 102 has a radius larger than the inner radius of the spring retainer 206, and portion 406b engages with the spring retainer 206 when the elongated member 102 is displaced to a distance similar to that of the spring retainer 206.

[0029] By displacing the elongated member 102 along the longitudinal axis of the tube assembly 104 toward the first end 112 of the tube assembly 104, the tip 308 of the elongated member 102 perforates a seal 402 that separates the volume of the first chamber 407 (Figure 4) from the volume of the second chamber 409. In some implementations, perforating the seal 402 and combining the volumes of both the first and second chambers allows the reagent to be mixed between both chambers. In some implementations, a solenoid is used to press a projection 316 of the spring retainer 206, removing the projection 316 from the key opening 212, causing a transition from the first configuration shown in Figure 4 to the second configuration shown in Figure 5. The spring retainer 206 may deform when the projection 316 is pressed, and as a result, at least a portion of the spring retainer 206 including the projection 316 has a deformed cross-section compared to the portion of the spring retainer 206 that slides with the elongated member 102.

[0030] In some implementations, the inspection device 100 is a single-use, disposable multi-chamber device to prevent cross-contamination. The solenoid that initiates the transition from the first configuration to the second configuration can be part of a reusable device controlled by an electronic circuit, which controls the timing of the reaction (and other functions such as heating or fluorescence analysis). The spring 204 is provided so as to be located within the tube assembly 104, but in some implementations, the spring 204 is simply a mechanism that provides mechanical energy, allowing the elongated member 102 to be controlledly advanced along the tube assembly 104. That is, the spring 204 can be part of a reusable device that houses the solenoid. For example, the spring 204 may include the use of pneumatic or compressed gas, or other mechanisms for generating potential energy, or a simple electromagnet.

[0031] The first and second configurations are shown in Figures 4 and 5, respectively, but some implementations of the present disclosure include inspection devices with more than two chambers. Such inspection devices can be stacked to move fluid between more than two chambers provided, for example, from chamber 1 to chamber 2 with the first trigger, then from chamber 2 to chamber 3 with the second trigger, then from chamber 3 to chamber 4 with the third trigger, and so on. Multiple chambers may be separated by seals (e.g., seal 402). In some implementations, the first cylindrical member 202 may be provided with multiple key openings (e.g., key opening 212), so that the spring retainer 206 transitions between unlocking and locking to a series of key openings toward the first end 112 of the pipe assembly 104 after each successive trigger.

[0032] In some implementations, each consecutive chamber may contain a different reagent than the adjacent chamber. For example, the first chamber may contain a first reagent, and the second chamber may contain a second reagent. The first reagent may be different from the second reagent. Similarly, the second and third chambers may have different reagents, and as a result, the second reagent in the second chamber is different from the third reagent in the third chamber. In some implementations, the third reagent is the same as the first reagent. In some implementations, instead of having different reagents, each chamber is kept at a different temperature. In some implementations, different temperature combinations may be used in different chambers.

[0033] Figure 6-1 shows a cross-section of an inspection device 600 according to several implementations of the present disclosure. The inspection device 600 includes an elongated member 602 and a pipe assembly 604. The pipe assembly 604 includes a first chamber casing 606, in which at least a portion of the first chamber casing 606 defines a first chamber 607, and a second chamber casing 608 defining a second chamber 609. In Figure 6, the first chamber casing 606 is a continuous portion and provides a similar function to the joint between the first chamber casing 208 (Figure 4) and the first cylindrical member 202 (Figure 4). The pipe assembly 604 includes a key opening 612 and a seal 616, which are similar to the key opening 212 (Figure 4) and seal 402 (Figure 4). The inspection device 600 is shown in a first configuration, in which the tip 614 of the elongated member 602 is located within the first chamber 607 and the seal 616 is not perforated. The tube assembly 604 may include a cap 610. The cap 610 may be removed before inserting the elongated member 602, or in some implementations, the cap 610 includes a membrane that can be perforated by the elongated member 602 when inserted into the tube assembly 604.

[0034] Figures 6-2, 6-3, and 6-4 show cross-sections of inspection devices 620, 640, and 660 according to several implementations of the present disclosure, respectively. Inspection devices 620 and 640 are shown in a first configuration, in which the tip 634 (654) of an elongated member 622 (642) is positioned within the first chamber 627 (647) of inspection device 620 (640). The second chamber 629 (649) of inspection device 620 (640) remains sealed and is separated from the first chamber 627 (647). The first chamber 627 (647) is defined by the first chamber casing 625 (645). Inspection device 660 is shown in a second configuration, in which the tip 675 of an elongated member 662 is positioned within the second chamber 669 of inspection device 660.

[0035] In the inspection device 100 of Figure 4, the spring retainer 206 is positioned such that when in the locked position, the spring 204 compresses only a small portion of one end of the spring retainer 206. In Figures 6-2 to 6-4, the inspection devices 620, 640, and 660 have spring retainers 631, 651, and 671, which are positioned such that the springs 633, 653, and 673 compress substantially the entire spring retainers 631, 651, and 671, respectively. When in the locked position, the spring retainers 631, 651, and 671 are compressed by the springs 633, 653, and 673, so that the projections 632, 652, and 672 prevent the movement of the spring retainers 631, 651, and 671, and the force of the springs 633, 653, and 673 is transmitted through the spring retainers 631, 651, and 671 in whole or substantially throughout.

[0036] Compared to inspection devices 620 and 640, inspection device 660 is shown in a second configuration. Inspection device 660 includes a first key opening 674 and a second key opening 670. The first key opening 674 is similar to the key opening 212 (Figure 4), and in the first configuration, the projection 672 can prevent the spring retainer 671 from moving toward the second chamber 669 of inspection device 660. The second key opening 670 is optional and is provided as a second alternative to prevent the spring retainer 671 from moving further toward the second chamber 669 in the second configuration.

[0037] Figure 6-4 shows the inspection device 660 of the second configuration, which includes several safety devices to prevent the elongated member 662 from moving further when the tip 675 is located inside the second chamber 669. For example, the shape of the first chamber casing 665 that interfaces with the shape of the elongated member 662 can prevent further movement, and the spring retainer 671 that abuts against the first chamber casing 665 can prevent further movement, and so on.

[0038] The tube assemblies 624, 644, and 664 of the inspection devices 620, 640, and 660 each have first cylindrical members 626, 646, and 666, respectively, equipped with flanges 623, 643, and 663. The flanges 623, 643, and 663 can assist in the vertical positioning of the tube assemblies 624, 644, and 664 within the holder, and the flanges 623, 643, and 663 serve as contact points between the tube assemblies 624, 644, and 664 and the holder. Furthermore, the second chamber casings 628, 648, and 668 have different shapes and are thinner, for example, compared to the second chamber casing 210 in Figure 4. The tube assemblies 620 and 660 may be suitable for optical reading, and the tube assembly 640 may be used for laboratory standard "650 μl" tubes.

[0039] Figure 7 shows a process for performing a test according to several implementations of the present disclosure. Step 702 shows an electronic device 710 having a visual indicator and / or button 716 and a receptacle 714 for receiving a tube assembly 712. The tube assembly 712 may be similar to or the same as the tube assembly 104 in Figure 1. Step 704 shows the tube assembly 712 inserted into the electronic device 710. Step 706 shows a subject 718 having a swab 720 for collecting a sample. The swab 720 may be similar to or the same as the elongated member 102 in Figure 1. Step 708 shows the swab 720 being inserted into the tube assembly 712 to perform a test on the collected sample. In some implementations, the sample is a biological sample obtained from an object requiring testing, e.g., a human subject. The biological sample may be a bodily fluid such as saliva, nasal mucus, or mucus. The biological sample may include cells or genetic material (e.g., nucleic acids), bacteria, viruses, fungi, or a combination thereof from the subject.

[0040] Figure 8A shows a cross-section of a first electronic device 800 according to several implementations of the present disclosure. The first electronic device 800 may include a microprocessor 802, one or more heaters (e.g., a 95°C heater, a 60°C heater, etc.), and a fluorometer 806 (e.g., a tricolor fluorometer). The one or more heaters may include a first heater 804a, a second heater 804b, or additional heaters. The microprocessor 802 is configured to interpret and provide a visual indicator based on the results provided by the fluorometer 806. In some implementations, the first electronic device 800 may be designed for a two-chamber tube assembly (e.g., tube assembly 104 in Figure 4). A first chamber (for example, the first chamber 407 in Figure 4) may be installed so that the first heater 804a of the first electronic device 800 maintains the first chamber at a first temperature (for example, 95°C), and the second heater 804b of the first electronic device 800 maintains the second chamber (for example, the second chamber 409 in Figure 4) at a second temperature (for example, 60°C).

[0041] Figure 8B shows a cross-section of a second electronic device 801 according to several implementations of the present disclosure. The second electronic device 801 is similar to the first electronic device 800, except that the second electronic device 801 includes a solenoid 810 which is used to remove a protrusion (e.g., protrusion 316 in Figure 4) and advance an elongated member (e.g., elongated member 102 in Figure 4) to perforate a membrane separating two chambers of an inspection assembly. The first electronic device 800 (Figure 8A) may be used with a tube assembly in which an operator needs to manually advance the elongated member, while the second electronic device 801 (Figure 8B) may be used with a tube assembly in which a spring retainer is removed by a solenoid (e.g., tube assembly 104 in Figure 4). The timing of the solenoid 810 in the second electronic device 801 can be adjusted using a microprocessor 802 to achieve more precise timing for advancing the elongated member. Figure 9 shows a modular assembly of electronic devices according to several implementations of the present disclosure. In one example, for large-scale testing, the electronic devices (e.g., electronic device 800 or 801) may be arranged as shown in Figure 9.

[0042] Figure 10 shows an inspection device 1000 according to several implementations of the present disclosure. The inspection device 1000 includes an elongated member 1002 and a pipe assembly 1004. Figure 11 shows a cross-section of the inspection device 1000 according to several implementations of the present disclosure. The elongated member 1002 includes a push button 1010 to facilitate the operator or user pushing the elongated member 1002 into the pipe assembly 1004. The elongated member 1002 further includes a plurality of unidirectional retainers that can clip the elongated member 1002 to the pipe assembly 1004 at various points 1012 as the elongated member 1002 is pushed into the pipe assembly 1004. In some implementations, a click sound is generated when the elongated member 1002 is pushed into the pipe assembly 1004. The clicking sound can provide the operator with a human-recognizable indicator that the elongated member 1002 is positioned in the first chamber, second chamber, third chamber, etc., of the tube assembly 1004. This human-recognizable indicator allows the user to know how far the elongated member 1002 should be pushed in as the response progresses. In some implementations, the elongated member 1002 is shaped such that once it reaches a stopper, a greater force is required to push it to reach the next stopper. This force feedback can be used to indicate to the operator or user how far the elongated member 1002 has been pushed into the tube assembly 1004. The manual push-in inspection device 1000 may be used with the electronic device 800 shown in Figure 8A, while the inspection device 100 in Figure 4 may be used with the electronic device 801 shown in Figure 8B. Figure 11 also shows how the first heater 804a and the second heater 804b engage with the pipe assembly 1004.

[0043] Figures 10 and 11 illustrate the concept in the context of human-assisted pushing, but other pushing mechanisms may be used. For example, the elongated member 1002 may be pushed into the tube assembly 1004 using force applied from an external mechanism such as a spring. In some implementations, the external mechanism may include a geared motor, server, pneumatic piston, etc.

[0044] Figure 12A shows a cross-section of the inspection device 1200 according to several implementations of the present disclosure. Figures 12B to 12E show different locations of the inspection device 1200. The inspection device 1200 includes a pipe assembly 1204 and an elongated member 1202. The elongated member 1202 includes a push button 1201 and a spring 1203. The pipe assembly 1204 includes a first chamber casing 1208 defining a first chamber and a second chamber casing 1210 defining a second chamber. The first chamber casing 1208 also includes a thin portion 1207 that can be deformed and activated by a solenoid. In Figure 12B, the pipe assembly 1204 and the elongated member 1202 are separated. In Figure 12C, the pipe assembly 1204 receives the elongated member 1202 until it is caught in the retainer portion 1206 of the first chamber casing 1208. The retainer portion 1206 prevents the elongated member 1202 from advancing beyond the first chamber.

[0045] In Figure 12D, pushing the push button 1201 further downward compresses the spring 1203 while the elongated member 1202 remains inside the first chamber. The push button 1201 is caught by the retainer of the tube assembly 1204, and the compression spring 1203 remains compressed. In Figure 12E, a solenoid can be used to deform the thin portion 1207 of the first chamber casing 1208, resulting in the expansion of the retainer portion 1206 by a pinching effect. This expansion allows the spring 1203 to advance the elongated member 1202 into the second chamber, as shown in Figure 12E. Comparing Figures 12D and 12E, the spring 1203 is compressed in Figure 12D and depressurized in Figure 12E.

[0046] Figure 13 shows a cross-section of a testing device 1300 according to several implementations of the present disclosure. The testing device 1300 includes a cotton swab 1301 inserted in sample collection and an extraction chamber 1302. The cotton swab 1301 includes a tip 1304 containing the sample. The sample and collection chamber 1302 may include a "washboard" shape 1303 so that when the tip 1304 of the cotton swab 1301 is inserted into the sample and collection chamber 1302, the washboard shape 1303 can deform and knead the tip 1304, helping to release the sample into the extraction buffer present in the sample and collection chamber 1302. The washboard shape 1303 frees the user from further manipulation of the cotton swab 1301 for optimal sample extraction. The extraction buffer present in the sample and collection chamber 1302 may include a nucleic acid extraction buffer. The nucleic acid extraction buffer can facilitate a chemical reaction that results in the extraction of nucleic acids from the sample on the tip 1304 of the cotton swab 1301.

[0047] The inspection device 1300 is similar to the inspection device 100 (Figure 4) in that the spring and spring retainer are located within a hollow tubular member. The inspection device 1300 includes a first spring 1305 located within a first hollow tubular member 1307, which is shown compressed in Figure 13 by a first spring retainer 1306. The first spring retainer 1306 operates within the first hollow tubular member 1307 in the same manner as described above in Figure 4 with respect to the first cylindrical member 202. When the first spring retainer 1306 is released, the first spring 1305 depressurizes, pushing the first spring retainer 1306 and creating a vacuum within the chamber in the first hollow tubular member 1307 where the first spring 1305 is located. Creating a vacuum within the chamber causes tension on the sample and the mixture of the sample and extraction buffer in the collection chamber 1302. In other words, the higher pressure (e.g., atmospheric pressure) within the sample and collection chamber 1302 pushes the sample and extraction buffer mixture through the resulting vacuum. The sample and extraction buffer mixture flows from the sample and collection chamber 1302 through the flexible ball 1308, which acts as a check valve. The sample and extraction buffer mixture further flows through the frit (and / or filter) 1312. Although described in the context of generating a vacuum, the release of the first spring 1305 can generate a vacuum, or in some implementations, positive pressure, within the hollow tube member 1307.

[0048] The frit (and / or filter) 1312 may hold silica purification beads for filtering particles from a mixture of sample and extraction buffer, as the mixture is guided through the frit (and / or filter) 1312 by the generated vacuum. The inspection apparatus 1300 further includes a second tubular member 1311 with a second spring 1309 and a second spring retainer 1310. The second spring 1309 and the second spring retainer 1310 facilitate the pushing (or injection) of fluid present in the second tubular member 1311 through the silica beads provided in the frit (and / or filter) 1312. A flexible ball 1308 acts as a check valve to prevent the pushed (or injected) fluid from entering the sample and collection chamber 1302. A post-wash / concentration reaction chamber 1313 is provided within the inspection apparatus 1300 to collect the fluid.

[0049] The components in Figure 13 are connected in different orientations, sizes, and shapes, which may result in flows in different directions. Figure 13 shows the use of a spring / solenoid system to automate the passage and elution of silica beads or other filters, and to wash and / or concentrate samples such as saliva or nasal mucus.

[0050] Figure 13-1 shows one embodiment of the inspection apparatus 1300 of Figure 13. The first chamber 1350 contains a buffer solution into which a cotton swab (e.g., cotton swab 1301 in Figure 13) is immersed. The buffer solution is discharged from the first chamber 1350 to the waste chamber 1352 via capillaries 1363b, 1363e, and 1363f. On its way to the waste chamber 1352, the buffer solution passes through silica at position 1362. The silica filters out the particles of interest as the buffer solution passes through. Next, the spring 1360 is released by activating a spring retainer 1358 that pushes a stopper 1356. The spring retainer 1358 may be released by, for example, a solenoid, according to some implementations of this disclosure. The stopper 1356 pushes the fluid contained in the chamber 1354. In some implementations, the fluid is an amplification buffer, and the stopper 1356 pushes the amplification buffer from chamber 1354 through capillaries 1363a and 1363c to the lower chamber 1364. The amplification buffer also passes through position 1362 on its way to the lower chamber 1364, and is therefore also filtered in the process. Because the diameters of the capillaries 1363a-f are small, the movement of the fluid is guided by the negative and positive pressures generated in either the waste chamber 1352 or chamber 1354. This is because gravity alone would not be expected to easily move the fluid through the narrow capillaries 1363a-f.

[0051] In Figure 13-1, in several implementations, the waste chamber 1352 includes a spring and spring retainer configuration that can generate negative pressure to guide the buffer through capillaries 1363e, 1363f, and 1363b. Furthermore, when released, spring 1360 can generate positive pressure to push the amplification buffer from chamber 1354 through capillaries 1363a and 1363f into the lower chamber 1364. When released, spring 1360 generates negative pressure through capillary 1363d, supplementing the positive pressure. Using Figure 13, in contrast, a first hollow tube member 1307 can function as a waste chamber with a first spring 1305 used to generate negative pressure to draw the sample and extraction buffer into the first hollow tube member 1307. A second spring 1309 can be used to generate positive pressure within the second hollow tube member 1311, thereby pushing the amplification buffer into the wash / concentration reaction chamber 1313.

[0052] Figure 14 shows a cross-section of the inspection apparatus 1400 according to several implementations of the present disclosure. The inspection apparatus 1400 operates similarly to the inspection apparatus 1300 in Figure 13. A cotton swab 1401 is inserted into the sample collection and extraction chamber 1402, which may have a washboard shape for automating swab kneading. A first starter spring 1405 can be used to vacuum the sample through silica beads contained in a frit and / or filter 1412. The frit and / or filter 1412 is provided to hold the silica purification beads. A second spring 1409 can be used to push the elution / reaction buffer through the beads in the frit and / or filter 1412 into the amplification chamber 1413. A flexible ball 1408 may be provided to act as a check valve. The amplification chamber 1413 functions as a concentration reaction chamber after washing. The inspection apparatus 1400 in Figure 14 is included in a single cylindrical design compared to the inspection apparatus in Figure 13.

[0053] The components are connected in different orientations, sizes, and shapes, and flows in different directions can occur. Similar to Figure 13, Figure 14 shows the use of a spring / solenoid system to automate the passage and elution of silica beads or other filters, and to wash and / or concentrate samples such as saliva or nasal mucus.

[0054] Figure 15 shows the steps for using the testing apparatus 1500 according to several implementations of the present disclosure. The testing apparatus 1500 is similar to and operates similarly to the testing apparatus 1400 in Figure 14. Inset (A) of Figure 15 shows the first step in which the cotton swab is eluted; inset (B) of Figure 15 shows the second step in which the first spring is activated; inset (C) of Figure 15 shows the third step in which the sample is supplied; inset (D) of Figure 15 shows the fourth step in which the second spring is activated; and inset (E) of Figure 15 shows the fifth step in which the sample is eluted.

[0055] In the inset (A) of Figure 15, the cotton swab 1501 is inserted into the extraction buffer 1502 in the first chamber of the testing apparatus 1500. The freeze-dried pellet 1503 is supplied to the second chamber of the testing apparatus 1500 as shown. The cotton swab 1501 is immersed in the extraction buffer 1502 for a predetermined time. The testing apparatus 1500 includes a plurality of spring chambers. In Figure 15, the testing apparatus 1500 includes two spring chambers (a first spring chamber 1504a having a first spring 1505a and a second spring chamber 1504b having a second spring 1505b). Spring chambers 1504a and 1504b each include spring retainers 1506a and 1506b, respectively, which maintain the springs 1505a and b in spring chambers 1504a and b in a pre-compressed state. Spring retainers 1506a and 1506b are similar to or identical to the spring retainers described above in relation to Figure 4. Filter 1507 is also included in the inspection device 1500.

[0056] In the inset (B) of Figure 15, the first spring 1505a is actuated. The first spring 1505a is actuated in the same manner as described above in connection with the release of the spring retainer, according to some implementations of the present disclosure. When actuated, the first spring 1505a generates a vacuum pressure that draws a fluid (e.g., extraction buffer 1502) from the first chamber of the inspection apparatus 1500 into the first spring chamber 1504a. The path of the fluid flow is indicated by arrow 1508, and the first spring 1505a when released is as shown in the inset (C) of Figure 15. The fluid drawn into the first spring chamber 1504a passes through the filter 1507, thereby retaining the target particles from the cotton swab 1501, and the fluid 1509 generated in the first spring chamber 1504a becomes waste liquid.

[0057] In the inset (D) of Figure 15, the second spring 1505b is actuated. The second spring 1505b is actuated in a manner similar to that described above in connection with the release of the spring retainer, according to some implementations of the present disclosure. When actuated, the second spring 1505b pushes the second fluid 1510 from the second spring chamber 1504b into the second chamber containing the lyophilized pellet 1503. The second fluid 1510 may be an elution or amplification buffer. Inset (E) of Figure 15 shows the positions of the first and second fluids after both springs 1505a and b have been actuated. The mixture 1511 contains the lyophilized pellet 1503.

[0058] In Figures 13, 14, and 15, the fluid being extruded is labeled as an amplification buffer, but it may be an elution buffer. The amplification buffer may be a nucleic acid amplification reagent, including an isothermal nucleic acid amplification reagent. The nucleic acid amplification reagent may include polymerase chain reaction (PCR) reagents, recombinase polymerase amplification (RPA) reagents, loop-mediated isothermal amplification (LAMP) reagents, rolling circle amplification (RCA) reagents, or strand displacement amplification (SDA) reagents.

[0059] In some implementations, the nucleic acid amplification reagent is lyophilized. In some implementations, the chemical reaction occurring in a second chamber (e.g., mixture 1511 in the second chamber in inset (E) of Figure 15) is a nucleic acid amplification reaction. The nucleic acid amplification reaction may be PCR, RPA, LAMP, etc. In some implementations, the second chamber contains a nucleic acid probe containing a reporter molecule capable of generating a detectable signal. The nucleic acid probe may contain a nucleotide sequence substantially complementary to the amplicon from the nucleic acid amplification. The second chamber may contain an exonuclease. The exonuclease may be a double-strand specific exonuclease with exonuclease activity in the 5'→3' direction.

[0060] In Figures 13, 14, and 15, the sample is processed through a series of steps to obtain a processed sample in a second chamber (e.g., the lower chamber in Figure 15). Rather than simply heating the sample in the first / intermediate chamber, a laboratory-standard "silica-based RNA / DNA purification" scheme is employed to remove impurities. In some implementations, 90% to 99% or more of non-nucleic acid impurities such as proteins, sugars, cell debris, and buffer components are removed. The final nucleic acid concentration may be lower, the same as, or higher than the original concentration, and both purification and / or concentration modification are possible. This scheme involves (i) mixing the sample with a larger volume of buffer in the first chamber, (ii) binding the nucleic acid as the sample / buffer passes through a silica pellet and is pulled by a piston / spring into the waste chamber, and (iii) using a second spring to deliver the elution buffer through the silica to the lower reaction chamber.

[0061] In some implementations, the system is configured with opposing springs within a single tube, allowing for the expulsion and retraction of fluid within the tube. In some implementations, the opposing springs allow the swab to move forward or backward from one chamber to another within the tube. Multiple spring retainers may be used in these implementations to allow the piston or swab to return to its previous position.

[0062] Figures 13–15 use amplification buffers and amplification reactions as examples. As used herein, “amplification” is defined as the production of additional copies of a nucleic acid sequence, i.e., amplicons or amplification products. Methods for amplifying nucleic acid sequences include, but are not limited to, isothermal amplification, polymerase chain reaction (PCR), and various types of PCR, such as rapid amplification of cDNA ends (RACE), ligase chain reaction (LCR), multiplex RT-PCR, immunoPCR, SSIPA, real-time RT-qPCR, and nanofluidic digital PCR.

[0063] Non-limiting examples of isothermal amplification include recombinase polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), helicase-dependent isothermal DNA amplification (HDA), rolling circle amplification (RCA), nucleic acid sequence-based amplification (NASBA), strand-displacement amplification (SDA), nickel enzyme amplification (NEAR), and polymerase spiral reaction (PSR). For example, see Yan et al., "Isothermal amplified detection of DNA and RNA," March 2014, Molecular BioSystems 10(5), DOI:10.1039 / c3mb70304e, the entire content of which is incorporated herein by reference.

[0064] In some implementations, the sample includes nucleic acid molecules (e.g., RNA or DNA) extracted from subjects, viruses, bacteria, etc. RNA as used herein may be any known type of RNA. For example, RNA may include messenger RNA, mRNA precursors, ribosomal RNA, signal recognition particle RNA, transfer RNA, transfer messenger RNA, nuclear small RNA, nucleolar small RNA, SmY RNA, Cajal body-specific small RNA, guide RNA, ribonuclease P, ribonuclease MRP, Y RNA, telomerase RNA elements, splice leader RNA, antisense RNA, cis-natural antisense transcripts, CRISPR RNA, long non-coding RNA, microRNA, Piwi-interacting RNA, small interfering RNA, short hairpin RNA, trans-acting siRNA, repeat-associated siRNA, 7SK RNA, enhancer RNA, parasitic RNA, type, retrotransposon, viral genome (e.g., viral RNA), viroid, satellite RNA, or vault RNA. The DNA used herein may include genomic DNA, mitochondrial DNA, viral DNA, complementary DNA (cDNA), single-stranded DNA, double-stranded DNA, circular DNA, and the like.

[0065] In some implementations, the viral genome is extracted from RNA viruses that are Group III (i.e., double-stranded RNA (dsRNA)) viruses. In some implementations, Group III RNA viruses belong to a viridae selected from the group consisting of Amargaviridae, Birnaviridae, Chrysoviridae, Cystoviridae, Endornaviridae, Hypoviridae, Megabirnaviridae, Partitiviridae, Picobirnaviridae, Reoviridae (e.g., rotavirus), Tochiviridae, and Quadriviridae. In some implementations, Group III RNA viruses belong to the genus Botivirnavirus. In some implementations, Group III RNA viruses are unclassified species selected from a group consisting of Botrytis porri RNA virus 1, Circulifer tenellus virus 1, Colletotrichum camelliae filamentous virus 1, Cucurbit yellows associated virus, Sclerotinia sclerotiorum debilitation-associated virus, and Spissistilus festinus virus 1.

[0066] In some implementations, the viral genome is extracted from RNA viruses that are Group IV (i.e., single-stranded positive-chain (ssRNA)) viruses. In some implementations, Group IV RNA viruses belong to a viral order selected from the Nidovirales, Picornaviridae, and Thymovirales. In some implementations, Group IV RNA viruses belong to families such as Alteriviridae, Coronaviridae (e.g., coronavirus, SARS-CoV), Mesonyviridae, Roniviridae, Disistroviridae, Ifraviridae, Marnaviridae, Picornaviridae (e.g., poliovirus, rhinovirus (common cold virus), hepatitis A virus), Secoviridae (e.g., Subcomoviridae), Alphaflexiviridae, Betaflexiviridae, Gammaflexiviridae, Thymoviridae, Alphatetraviridae, Alvernaviridae, Astroviridae, Varnaviridae, Beniviridae, Bromoviridae, and Caliciviridae (Norwalk virus, etc.). ) It belongs to a viridae selected from the group consisting of Carmotetraviridae, Closteroviridae, Flaviviridae (e.g., yellow fever virus, West Nile virus, hepatitis C virus, dengue fever virus, Zika virus), Fusariviridae, Hepeviridae, Hypoviridae, Leviviridae, Luteoviridae (e.g., barley yellow dwarf virus), Polyshipiviridae, Narunaviridae, Nodaviridae, Permutotetraviridae, Potiviridae, Sarsuloviridae, Statoviridae, Togaviridae (e.g., rubella virus, Ross River virus, Sindbis virus, Chikungunya virus), Tombusviridae, and Birgaviridae. In some implementations, Group IV RNA viruses belong to a virus genus selected from the group consisting of Bacillariornavirus, Disipivirus, Rabirnavirus, Cekivirus, Blunervirus, Silevirus, Hygrevirus, Idaeovirus, Naeghevirus, Ourmyavirus, Polemovirus, Sinaivirus, and Sobemovirus.In some implementations, Group IV RNA viruses include Acyrthosiphon pisum virus, Bastrovirus, Blackford virus, Blueberry necrotic ring blotch virus, Cadicistrovirus, Chara australis virus, Extra small virus, Goji berry chlorosis virus, Hepelivirus, Jingmen tick virus, Le Blanc virus, Nedicistrovirus, Nesidiocoris tenuis virus 1, Niflavirus, Nylanderia fulva virus 1, Orsay virus, Osedax japonicus RNA virus 1, Picalivirus, and Plasmoparavirus (Sunflower downy mildew). Group IV RNA viruses are unclassified species selected from a group consisting of halstedii virus, white root rot fusari virus 1 (Rosellinia necatrix fusarivirus 1), Santeuil virus, Secalivirus, fire ant virus 3 (Solenopsis invicta virus 3), and Wuhan large pig roundworm virus. In some implementations, Group IV RNA viruses are satellite viruses selected from a group consisting of the family Sarsuroviridae, genera Albetovirus, Aumaivirus, Papanivirus, Virtovirus, and chronic bee paralysis virus.

[0067] In some implementations, the viral genome is extracted from RNA viruses that are group V (i.e., single-stranded negative-sense RNA) viruses. In some implementations, group V RNA viruses belong to a phylum or subphylum of viruses selected from the group consisting of the phylum Negarnaviri, subphylum Haplovirus, and subphylum Polyprovirus. In some implementations, group V RNA viruses belong to a viral class selected from the group consisting of Chunqiuviricetes, class Erioviri, class Instviri, class Milneviricetes, class Monviri, and class Yunchangviricetes. In some implementations, group V RNA viruses belong to a viral order selected from the group consisting of the orders Articulavirales, Bunyaviroides, Goujianvirales, Jingchuvirales, Mononegavirales, Muvirales, and Serpentovirales. In some implementations, group V RNA viruses belong to families such as Amnounviridae (e.g., Taastrup virus), Arenaviridae (e.g., Lassa virus), Aspiviridae, Bornaviridae (e.g., Borna disease virus), Chuviridae, It belongs to a viridae family selected from the group consisting of Cururiviridae, Feraviridae, Filoviridae (e.g., Ebola virus, Marburg virus), Phymoviridae, Hantaviridae, Jonviridae, Mymonaviridae, Nairoviridae, Niyamiviridae, Orthomyxoviridae (e.g., influenza virus), Paramyxoviridae (e.g., measles virus, mumps virus, Nipah virus, Hendra virus, and NDV), Peribunyaviridae, Phasmaviridae, Phenuiviridae, Pneumoviridae (e.g., RSV and metapneumovirus), Qinviridae, Rhabdoviridae (e.g., rabies virus), Sunviridae, Tospoviridae, and Yueviridae.In some implementations, Group V RNA viruses belong to a virus genus selected from the group consisting of Anphevirus, Arlivirus, Chengtivirus, Crustavirus, Tilapineviridae, Wastrivirus, and deltavirus (e.g., hepatitis D virus).

[0068] In some implementations, the viral genome is extracted from an RNA virus that is a group VI RNA virus, and it contains a reverse transcriptase encoded by the virus. In some implementations, group VI RNA viruses belong to the order Ortervirales of the order Virales. In some implementations, group VI RNA viruses belong to a viridae or subfamily selected from the group consisting of Belpaoviridae, Kalimoviridae, Metaviridae, Pseudoviridae, Retroviridae (e.g., retroviruses, e.g., HIV), Orthoretrovirinae, and Supamaretrovirinae. In some implementations, Group VI RNA viruses belong to a group of viral genomes selected from the following: alpha-retroviruses (e.g., avian leukemia virus, Rous sarcoma virus), beta-retroviruses (e.g., mouse mammary tumor virus), bovispumaviruses (e.g., bovine formivirus), delta-retroviruses (e.g., bovine leukemia virus, human T-lymphocyte-targeting virus), epsilon-retroviruses (e.g., pollock dermatosarcoma virus), Equispumaviruses (e.g., equine formivirus), Felispumaviruses (e.g., feline formivirus), gamma-retroviruses (e.g., mouse leukemia virus, feline leukemia virus), lentiviruses (e.g., human immunodeficiency virus 1, simian immunodeficiency virus, feline immunodeficiency virus), prosimyspumaviruses (e.g., Brown greater galago prosimian formivirus), and simyspumaviruses (e.g., Eastern chimpanzee simian formivirus).

[0069] In some implementations, the viral genome is extracted from an RNA virus selected from influenza virus, human immunodeficiency virus (HIV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In some implementations, the RNA virus is influenza virus. In some implementations, the RNA virus is immunodeficiency virus (HIV). In some implementations, the RNA virus is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

[0070] In some implementations, viral RNA is an RNA molecule produced by viruses that have a DNA genome, i.e., DNA viruses. As a non-restrictive example, DNA viruses include group I (dsDNA) viruses, group II (ssDNA) viruses, or group VII (dsDNA-RT) viruses.

[0071] While the disclosed embodiments have been illustrated and described in relation to one or more implementations, equivalent changes and modifications will be conceivable or well known to those skilled in the art through careful reading and understanding of this specification and the accompanying drawings. Furthermore, certain features of the present invention may be disclosed in relation to only one of several implementations, but such features can be combined with one or more other features of other implementations so as to be desirable and advantageous for any given application, or for a particular application.

[0072] One or more elements, aspects, or steps, or any part thereof, from any one or more of the following claims 1 to 53 may be combined with one or more elements, aspects, or steps, or any part thereof, from any one or more of the other claims 1 to 53, or any combination thereof, to form one or more additional implementations and / or claims of the present disclosure.

[0073] While various embodiments of this disclosure have been described above, it should be understood that these are presented only as examples and are not limiting. Many modifications to the disclosed embodiments can be made in accordance with the disclosure herein without departing from the spirit or scope of this disclosure. Therefore, the breadth and scope of this disclosure should not be limited by any of the embodiments described above. Rather, the scope of this disclosure should be defined in accordance with the following claims and equivalents.

Claims

1. 1. An apparatus comprising: A long and thin member; a tube assembly having a first end and a second end and configured to receive the elongated member at the second end; The tube assembly comprises: a plurality of chambers including a first chamber and a second chamber separated by a membrane; a spring disposed at the second end of the tube assembly; a spring retainer configured to prevent the spring from decompressing when in a locked position and to allow the spring to decompress when in an unlocked position; Including, Device.

2. The apparatus of claim 1 , wherein the tube assembly further includes a key opening for receiving a portion of the spring retainer when the spring retainer is in the locked position.

3. The apparatus of claim 2 , wherein a longitudinal axis of the tube assembly and an axis of the key opening are orthogonal.

4. The apparatus of claim 2 or 3, wherein removing the portion of the spring retainer from the key opening places the spring retainer in the unlocked position.

5. The apparatus of claim 4 , wherein the shape of the spring retainer is deformed when the portion of the spring retainer is removed from the keyed opening.

6. The apparatus of any one of claims 1 to 5, wherein the spring is configured to urge the spring retainer towards the first end of the tube assembly when in the unlocked position.

7. The apparatus of claim 6 , wherein the elongated member moves toward the first end of the tube assembly as the spring retainer is urged toward the first end of the tube assembly.

8. 8. The apparatus of claim 6 or 7, wherein the elongated member pierces the membrane separating the first chamber from the second chamber in response to the spring retainer being urged toward the first end of the tube assembly.

9. An apparatus according to any one of claims 2 to 8, wherein the spring retainer is hollow, substantially cylindrical and has an inside radius smaller than an inside radius of the tube assembly.

10. An apparatus according to any preceding claim, wherein the elongate member has a cross-sectional area that varies along the length of the elongate member.

11. The apparatus of any one of claims 1 to 10, wherein the spring retainer is further configured to secure the elongated member within the tube assembly when received in the second end of the tube assembly.

12. The apparatus of any one of claims 1 to 11, wherein the elongated member includes a flap configured to prevent the elongated member from being removed from the tube assembly.

13. The device of any one of claims 1 to 12, wherein the first chamber contains a first reagent and the second chamber contains a second reagent different from the first reagent.

14. A device according to any one of claims 1 to 13, wherein the elongate member is a syringe or a cotton swab.

15. An apparatus as claimed in any preceding claim, wherein the spring retainer is transitioned from the locked position to the unlocked position using a solenoid.

16. The apparatus of any one of claims 1 to 15, wherein the spring comprises a compressed gas device or a mechanical spring.

17. The apparatus of any one of claims 1 to 16, wherein the plurality of chambers are arranged in series, the plurality of chambers further comprising at least a third chamber separated from the first chamber and the second chamber.

18. 18. An assembly for processing a plurality of samples comprising a plurality of devices according to any one of claims 1 to 17, said plurality of devices being arranged in an array and configured for processing said plurality of samples in parallel or in series.

19. 1. A method for conducting a chemical reaction, comprising: inserting the swab into a first chamber of the testing device, the first chamber containing a first fluid mixture; depressurizing a first spring disposed in a first spring chamber of the test device, the depressurization of the first spring causing the fluid mixture in the first chamber to flow into the first spring chamber of the test device, the fluid mixture being filtered by silica on its way to the first spring chamber; depressurizing a second spring disposed in a second spring chamber of the test fixture, the depressurization of the second spring causing a second fluid in the second spring chamber of the test fixture to be filtered by silica on its way to a second chamber; A method comprising:

20. A method for conducting a chemical reaction, comprising: inserting an end of an elongated member into a second end of a tube assembly such that the end of the elongated member extends into a first chamber of the tube assembly; decompressing a spring disposed at the second end of the tube assembly by unlocking a spring retainer of the tube assembly; piercing a membrane separating the first chamber of the tube assembly from a second chamber of the tube assembly such that the one end of the elongated member extends into the second chamber of the tube assembly; A method comprising: